Johnson & Johnson vs Occidental Petroleum Corporation — how do they compare? Johnson & Johnson trades at $260.57 (market cap $626.09B), while Occidental Petroleum Corporation trades at $58.53 (market cap $55.89B). The key difference: Johnson & Johnson is far larger — about 11.2× Occidental Petroleum Corporation's market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | OXY | |
|---|---|---|
Market Cap | $626.09B | $55.89B |
Volume | 6,156,228 | — |
Sector | Health | Energy |
52-Week High | $267.24 | $66.24 |
52-Week Low | $172.78 | $38.92 |
Enterprise Value | $654.37B | $74.65B |
Dividend Yield | 2.06% | 2% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
Occidental Petroleum (OXY) trades at $58.65, up 4.9% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $2.40, exceeding expectations, and is focusing on debt reduction while targeting over $4 billion in annual sustainable cash flow by 2030. Valuation ratios remain reasonable with a P/E of 16.49 and EV/EBITDA of 5.26.
The outlook is positive, driven by operational outperformance and higher oil prices, but remains sensitive to commodity volatility. Analyst consensus is a Buy with a $69.33 price target, though execution risks and oil price dependence are key considerations for investors.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →